Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$2.58 - $3.97 $517,166 - $795,794
-200,452 Closed
0 $0
Q2 2019

Aug 16, 2019

BUY
$3.0 - $5.5 $5,595 - $10,257
1,865 Added 0.94%
200,452 $678,000
Q4 2018

Feb 13, 2019

SELL
$3.95 - $6.55 $42,877 - $71,100
-10,855 Reduced 5.18%
198,587 $806,000
Q2 2018

Sep 27, 2018

BUY
$5.05 - $7.35 $618,609 - $900,352
122,497 Added 140.89%
209,442 $1.45 Million
Q2 2018

Aug 10, 2018

SELL
$5.05 - $7.35 $618,609 - $900,352
-122,497 Reduced 58.49%
86,945 $9.69 Million
Q4 2017

Feb 14, 2018

BUY
$4.25 - $5.2 $25,959 - $31,761
6,108 Added 3.0%
209,442 $932,000
Q3 2017

Nov 14, 2017

BUY
$4.8 - $6.95 $976,003 - $1.41 Million
203,334
203,334 $1.08 Million

About MediWound Ltd.


  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $798M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.